Rachel Pearlman - Concepedia

Author

Rachel Pearlman

The Ohio State University ORCID

Also Known As

Pearlman, Rachel, Peters, Ulrike, R Pearlman, R. Pearlman, Rachel Pearlman, Southey, Melissa C., Taha Sachak

106

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University University of Washington The Ohio State University Wexner Medical Center Stanford University Institut d'Investigació Biomédica de Bellvitge

About

Rachel Pearlman is an author at The Ohio State University specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	19	2K
2	Public Health	4	4	939
3	Family Medicine	2	2	623
4	Health Sciences	1	1	23
5	Epidemiology	1	1	112

Rachel Pearlman

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer Rachel Pearlman, Wendy L. Frankel, Benjamin Swanson, JAMA Oncology	2016	698
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment Heather Hampel, Robin L. Bennett, Adam H. Buchanan, Genetics in Medicine Family MedicinePractice GuidelineGenetic TestingReferral IndicationsMedicine	2014	574
Colon and Endometrial Cancers With Mismatch Repair Deficiency Can Arise From Somatic, Rather Than Germline, Mutations Sigurdís Haraldsdóttir, Heather Hampel, Jerneja Tomšič, Gastroenterology Genome InstabilitySomatic VariantRather Than GermlineGeneticsGynecology	2014	370
Cancer Risks for <i>PMS2</i>-Associated Lynch Syndrome Sanne W. ten Broeke, Heleen M. van der Klift, Carli M.J. Tops, Journal of Clinical Oncology	2018	205
Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer Alexi Archambault, Yu‐Ru Su, Jihyoun Jeon, Gastroenterology Cancer RiskCancer EpidemiologyMedicineGeneticsCumulative Burden	2019	190
Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer Heather Hampel, Rachel Pearlman, Mallory Beightol, JAMA Oncology	2018	164
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival Casey Cosgrove, David E. Cohn, Heather Hampel, Gynecologic Oncology Epigenetic SilencingMedicineEpigenetic ChangeGynecologyPathology	2017	123
Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study Aung Ko Win, James G. Dowty, Jeanette C. Reece, The Lancet Oncology Lynch SyndromeRetrospective Cohort StudyCancer RiskCancer EpidemiologyMedicine	2021	112
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance Carol Durno, Ayse B. Ercan, Vanessa Bianchi, Journal of Clinical Oncology	2021	95
Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome Rachel Pearlman, Sigurdís Haraldsdóttir, Albert de la Chapelle, Journal of Medical Genetics	2019	93

Page 1